Search research articles
Contact Us
Filters
Showing results (301-310 of 335) with videos related to
Page
of 34
Sort By:
Transplantation and Cellular Therapy
|
January 2, 2025
Outcomes of Standard-Risk Multiple Myeloma Patients Who Undergo Upfront Autologous Hematopoietic Stem Cell Transplantation
Oren Pasvolsky, Curtis Marcoux, Zhongya Wang, et al.
Leukemia & Lymphoma
|
January 29, 2026
Lenalidomide maintenance after delayed or salvage autologous stem cell transplantation
Asad A Haider, Curtis Marcoux, Denái R Milton, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 27, 2026
Daratumumab-Based Second Line Therapy Improves Outcomes After VRD Induction, Upfront Autologous Transplant, and Lenalidomide Maintenance
Oren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
British Journal of Haematology
|
March 30, 2025
Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant response
Oren Pasvolsky, Muhammad Bilal Abid, Denái R Milton, et al.
Leukemia & Lymphoma
|
October 23, 2021
Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenance
Mahmoud R Gaballa, Junsheng Ma, Mark R Tanner, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
October 9, 2018
Copy-number variants in clinical genome sequencing: deployment and interpretation for rare and undiagnosed disease
Andrew M Gross, Subramanian S Ajay, Vani Rajan, et al.
Microbial Genomics
|
January 27, 2026
Optimizing data-driven excellence: Canada's approach to using pathogen test datasets for quality control, pipeline development and training initiatives
Kara D Loos, Mark Horsman, Jeff Tuff, et al.
Bone Marrow Transplantation
|
May 6, 2022
KRD vs. VRD as induction before autologous hematopoietic progenitor cell transplantation for high-risk multiple myeloma
Mahmoud R Gaballa, Junsheng Ma, Mikael Rauf, et al.
Blood Advances
|
April 8, 2025
Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel
Satabdi Saha, Lubna Rehman, Abdur Rehman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 14, 2016
NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017
Arnel Pallera, Jessica K Altman, Ellin Berman, et al.
Page
of 34
Search research articles
Search
Showing results (301-310 of 335) with videos related to
Sort By:
Page
of 34
Transplantation and Cellular Therapy
|
January 2, 2025
Outcomes of Standard-Risk Multiple Myeloma Patients Who Undergo Upfront Autologous Hematopoietic Stem Cell Transplantation
Oren Pasvolsky, Curtis Marcoux, Zhongya Wang, et al.
Leukemia & Lymphoma
|
January 29, 2026
Lenalidomide maintenance after delayed or salvage autologous stem cell transplantation
Asad A Haider, Curtis Marcoux, Denái R Milton, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 27, 2026
Daratumumab-Based Second Line Therapy Improves Outcomes After VRD Induction, Upfront Autologous Transplant, and Lenalidomide Maintenance
Oren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
British Journal of Haematology
|
March 30, 2025
Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant response
Oren Pasvolsky, Muhammad Bilal Abid, Denái R Milton, et al.
Leukemia & Lymphoma
|
October 23, 2021
Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenance
Mahmoud R Gaballa, Junsheng Ma, Mark R Tanner, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
October 9, 2018
Copy-number variants in clinical genome sequencing: deployment and interpretation for rare and undiagnosed disease
Andrew M Gross, Subramanian S Ajay, Vani Rajan, et al.
Microbial Genomics
|
January 27, 2026
Optimizing data-driven excellence: Canada's approach to using pathogen test datasets for quality control, pipeline development and training initiatives
Kara D Loos, Mark Horsman, Jeff Tuff, et al.
Bone Marrow Transplantation
|
May 6, 2022
KRD vs. VRD as induction before autologous hematopoietic progenitor cell transplantation for high-risk multiple myeloma
Mahmoud R Gaballa, Junsheng Ma, Mikael Rauf, et al.
Blood Advances
|
April 8, 2025
Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel
Satabdi Saha, Lubna Rehman, Abdur Rehman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 14, 2016
NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017
Arnel Pallera, Jessica K Altman, Ellin Berman, et al.
Page
of 34